Investigating the Combination PORCN Inhibitor, ETC-159, and Checkpoint Inhibitor Immunotherapy in Pre-Clinical Cancer Models

Administered By

Awarded By

Contributors

Start/End

  • May 23, 2018 - November 22, 2019